Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.9013.836.9827.27-0.66

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is 27.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.90
Mar202313.83
Mar20226.98
Mar202127.27
Mar2020-0.66

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98
-74.40
Mar2021 27.27
Positive
Mar2020 -0.66 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹120,857.3 Cr 7% 2.4% 0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,123.0 Cr 2.2% 3% 5.3% Stock Analytics
DIVIS LABORATORIES ₹152,844.0 Cr 8.9% 3.4% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,020.0 Cr -0.2% 5.4% 21.3% Stock Analytics
MANKIND PHARMA ₹104,071.0 Cr 2.1% 9.8% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,755.1 Cr 6.2% 3.5% -10.1% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

7%

2.4%

0.9%

SENSEX

5.3%

4%

3.2%


You may also like the below Video Courses